February 2018 Newsletter

February 22, 2018:

Ike Ahmed, MD, Describes Paradigm Shift in Eye Care During Keynote Address at Glaucoma 360 Meeting

The glaucoma specialist said doctors are intervening earlier and more aggressively to lower IOP.

February 22, 2018:

Shire Seeks to Make Xiidra a Global Product

The drugmaker plans to grow in ophthalmology by advancing its current pipeline and adding candidates for the posterior segment.

February 22, 2018:

FDA’s Gottlieb Appears to Soften Stance on Office-Use Compounding

US lawmakers tell the agency’s chief that recent policy shifts are creating supply chain vulnerabilities.

February 22, 2018:

Novartis Licenses Spark’s Retinal Gene Therapy Outside US in $170M Deal

Spark will commercialize its treatment in the US as Luxturna.

February 22, 2018:

ReVision Optics Closes Doors; Raindrop Inlay No Longer Available

US presbyopia market now has only one available inlay, the KAMRA.

February 22, 2018:

US Congress Suspends Medical Device Tax through 2019

The IRS collected $1.4 billion in medical device taxes in 2013 and $1.9 billion in 2014.

February 22, 2018:

Second Sight Reports Record Number of Argus II Implants in Q4-2017, First Orion Implant in Human

Argus II surgeries in 2017 rose 79 percent over the previous year.

February 22, 2018:

Omeros Loses Pass-through Status for Omidria

Surgeons use Omidria during cataract surgery for maintaining pupil size and reducing postoperative ocular pain.

February 22, 2018:

FDA Allows Outsourcing Facilities to Extend Beyond-Use Date for Repackaged Avastin

The agency will require additional sterility testing.

February 22, 2018:

Market Report: Surgery Growth Will Drive Retinal Device Market to $2.5 Billion by 2023

Market Scope estimates that more than 1.7 million vitrectomies will be performed globally in 2018.

February 22, 2018:

Second Trial for Ophthalmic Industry Leader James Mazzo Ends in Hung Jury, Mistrial

The jury was deadlocked 10-2 in favor of acquittal.

February 22, 2018:

Ophthalmic Funding: Aerie’s $74M Public Offering Tops List of Latest Financings

Five other companies raised funds in the past month, pushing the total to $144.4 million.

February 22, 2018:

Market Scope Weekly Polls

February 22, 2018:

February 2018 News Briefs

Social media